Test higher doses of oxfendazole against single-dose albendazole
Treatments studied
Part of Infections clinical trials.
This trial studies which dose of oxfendazole works best and is safest for treating a specific intestinal worm infection in adults. It compares different oxfendazole doses to one standard dose of albendazole, and uses stool and blood testing over about 4–6 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 18 to 65 (and weigh at least 45 kg).
- Your stool test within the last 14 days confirms you have Trichuris trichiura (a whipworm).
- You agree to collect about four stool samples and two blood samples over ~4–6 weeks.
- If you’ve had anti-worm medicine in the last 14 days, you can’t join.
- If you can become pregnant, you must have a negative pregnancy test and use effective birth control during the study and for about 28 days after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new combinations of deworming medicines to treat whipworm infection in school-aged children in Honduras. It aims to find a more effective treatment for children with this parasitic infection.
This Phase 1 trial tests how safe and tolerated orally taken Trichuris trichiura (a type of intestinal worm) eggs are in healthy adults. It aims to help researchers understand early safety and study setup before any future treatments.
This trial tests whether oxfendazole can better treat whipworm (Trichuris trichiura) in adults by checking stool samples before and after treatment. You may be eligible if you’ve recently had whipworm found in stool and can return for multiple follow-up samples.
This study tests whether one or two doses of oxfendazole (a newer drug) works as well as the standard two-dose triclabendazole treatment for chronic fascioliasis (liver fluke infection). It may offer a simpler treatment option.
This trial tests a new drug, emodepside, against the standard treatment albendazole for whipworm infection. It aims to see which is safer and works better in adolescents and adults.
This study compares three medicines (albendazole, tribendimidine, and praziquantel) to see which works best for treating clonorchiasis (a liver fluke infection). If you have been diagnosed with this infection, this trial may help find the most effective treatment for you.
Hear when a new Trichuriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.